Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06483451 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Facilitated Telemedicine in the Bassett Health System

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Dec 2026 → May 2027
See other at-risk trials from State University of New York at Buffalo

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jul 2026 to Dec 2026 Show 6 more changesShow less
    • Primary completion pushed from Dec 2026 to May 2027
    • Study completion pushed from Dec 2026 to Dec 2027
    • Study description shortened, about 6 words
    • Publications: details revised at 1 of 1 entry
    • Study title revised
    • Eligibility criteria expanded, about 2 words
  2. Primary and study completion dates: Apr 2026 to Dec 2026
    • Start date: Jan 2026 to Jul 2026
    v7
  3. Start date: Sep 2025 to Jan 2026
    • Primary and study completion dates: Dec 2025 to Apr 2026
    v6
  4. Start date: Jul 2025 to Sep 2025v5
  5. Start date: Jan 2025 to Jul 2025v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Dec 2024 to Dec 2025
    • Start date: Oct 2024 to Jan 2025
    • Study description revised
    v3
  2. Start date: Jul 2024 to Oct 2024v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Hepatitis C virus is a leading cause of morbidity and mortality globally with the highest prevalence and incidence among people with opioid use disorder. We aim to establish facilitated telemedicine as a standard of care treatment approach at 3 opioid treatment programs operated by the Catholic Health System. This study is a chart review data analysis to evaluate outcomes of facilitated telemedicine integrated into opioid treatment programs and to evaluate the number of individuals who initiate and complete treatment for hepatitis C virus infection.
Trial Details
NCT Number NCT06483451
Lead Sponsor State University of New York at Buffalo
Conditions
(from sponsor)		 HCV
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov